IBDEI0KV ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9886,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,9886,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,9887,0)
 ;;=364.51^^44^558^8
 ;;^UTILITY(U,$J,358.3,9887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9887,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,9887,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,9887,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,9888,0)
 ;;=364.53^^44^558^100
 ;;^UTILITY(U,$J,358.3,9888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9888,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,9888,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,9888,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,9889,0)
 ;;=364.57^^44^558^33
 ;;^UTILITY(U,$J,358.3,9889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9889,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,9889,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,9889,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,9890,0)
 ;;=364.60^^44^558^26
 ;;^UTILITY(U,$J,358.3,9890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9890,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,9890,1,4,0)
 ;;=4^364.60
 ;;^UTILITY(U,$J,358.3,9890,2)
 ;;=^268733
 ;;^UTILITY(U,$J,358.3,9891,0)
 ;;=364.73^^44^558^97
 ;;^UTILITY(U,$J,358.3,9891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9891,1,3,0)
 ;;=3^Peripheral Ant Synechiae
 ;;^UTILITY(U,$J,358.3,9891,1,4,0)
 ;;=4^364.73
 ;;^UTILITY(U,$J,358.3,9891,2)
 ;;=^268740
 ;;^UTILITY(U,$J,358.3,9892,0)
 ;;=364.75^^44^558^107
 ;;^UTILITY(U,$J,358.3,9892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9892,1,3,0)
 ;;=3^Pupillary Abnormalities
 ;;^UTILITY(U,$J,358.3,9892,1,4,0)
 ;;=4^364.75
 ;;^UTILITY(U,$J,358.3,9892,2)
 ;;=^268742
 ;;^UTILITY(U,$J,358.3,9893,0)
 ;;=364.76^^44^558^58
 ;;^UTILITY(U,$J,358.3,9893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9893,1,3,0)
 ;;=3^Iridodialysis
 ;;^UTILITY(U,$J,358.3,9893,1,4,0)
 ;;=4^364.76
 ;;^UTILITY(U,$J,358.3,9893,2)
 ;;=^265499
 ;;^UTILITY(U,$J,358.3,9894,0)
 ;;=364.77^^44^558^3
 ;;^UTILITY(U,$J,358.3,9894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9894,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,9894,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,9894,2)
 ;;=^268743
 ;;^UTILITY(U,$J,358.3,9895,0)
 ;;=364.89^^44^558^62
 ;;^UTILITY(U,$J,358.3,9895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9895,1,3,0)
 ;;=3^Iris/Ciliary D/O,Other
 ;;^UTILITY(U,$J,358.3,9895,1,4,0)
 ;;=4^364.89
 ;;^UTILITY(U,$J,358.3,9895,2)
 ;;=^268745
 ;;^UTILITY(U,$J,358.3,9896,0)
 ;;=364.9^^44^558^61
 ;;^UTILITY(U,$J,358.3,9896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9896,1,3,0)
 ;;=3^Iris/Ciliary Body D/O,Unspec
 ;;^UTILITY(U,$J,358.3,9896,1,4,0)
 ;;=4^364.9
 ;;^UTILITY(U,$J,358.3,9896,2)
 ;;=^123847
 ;;^UTILITY(U,$J,358.3,9897,0)
 ;;=370.00^^44^558^25
 ;;^UTILITY(U,$J,358.3,9897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9897,1,3,0)
 ;;=3^Corneal Ulcer NOS
 ;;^UTILITY(U,$J,358.3,9897,1,4,0)
 ;;=4^370.00
 ;;^UTILITY(U,$J,358.3,9897,2)
 ;;=^28441
 ;;^UTILITY(U,$J,358.3,9898,0)
 ;;=370.20^^44^558^66
 ;;^UTILITY(U,$J,358.3,9898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9898,1,3,0)
 ;;=3^Keratitis,Superfic Unspec
 ;;^UTILITY(U,$J,358.3,9898,1,4,0)
 ;;=4^370.20
 ;;^UTILITY(U,$J,358.3,9898,2)
 ;;=^268918
 ;;^UTILITY(U,$J,358.3,9899,0)
 ;;=370.31^^44^558^99
 ;;^UTILITY(U,$J,358.3,9899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9899,1,3,0)
 ;;=3^Phlyctenule Keratoconj
 ;;^UTILITY(U,$J,358.3,9899,1,4,0)
 ;;=4^370.31
 ;;^UTILITY(U,$J,358.3,9899,2)
 ;;=^268928^017.30
 ;;^UTILITY(U,$J,358.3,9900,0)
 ;;=370.8^^44^558^65
 ;;^UTILITY(U,$J,358.3,9900,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0KV
